Archived App (Last seen on 13 May 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This application offers an example of a regional citrate protocol for use with specific medical software and solutions. It serves as a reference for healthcare professionals, who should apply their own clinical judgment.
What's New in Prismaflex Citrate Protocol
1.1
October 6, 2020
Login functionality with bug fixes
Developer apps
FAQ
What is the Prismaflex Citrate Protocol app?
The Prismaflex Citrate Protocol app provides an example of a regional citrate protocol for use with Prismaflex eXeed II software and Baxter Haemofiltration solutions. It is intended as a reference for healthcare professionals.
Is the Prismaflex Citrate Protocol app free to use?
Yes, the Prismaflex Citrate Protocol app is available for free. There are no in-app purchases or advertisements associated with its use.
What devices does the Prismaflex Citrate Protocol app support?
The Prismaflex Citrate Protocol app is compatible with iPhone, iPad, and iPod devices.
How accurate is the information in the Prismaflex Citrate Protocol app?
The app provides an example protocol. Healthcare practitioners are advised to exercise their own independent clinical judgment when deciding to use this information.
When was the Prismaflex Citrate Protocol app last updated?
The Prismaflex Citrate Protocol app was last updated on October 6, 2020, with version 1.1.
What is the age rating for the Prismaflex Citrate Protocol app?
The Prismaflex Citrate Protocol app has an age rating of 4+.
Does the Prismaflex Citrate Protocol app require an internet connection?
The description does not specify if an internet connection is required. However, as it provides protocol examples, it may function offline.
Who developed the Prismaflex Citrate Protocol app?
The Prismaflex Citrate Protocol app was developed by Baxter Healthcare Corporation.
